Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3717-38-2 | MDL No. : | MFCD01674017 |
Formula : | C11H19N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NZOLSRPWNVZXTK-UHFFFAOYSA-N |
M.W : | 165.28 | Pubchem ID : | 19476 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 51.49 |
TPSA : | 12.03 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.21 cm/s |
Log Po/w (iLOGP) : | 2.49 |
Log Po/w (XLOGP3) : | 2.95 |
Log Po/w (WLOGP) : | 2.17 |
Log Po/w (MLOGP) : | 2.74 |
Log Po/w (SILICOS-IT) : | 2.28 |
Consensus Log Po/w : | 2.53 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.364 mg/ml ; 0.0022 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.87 |
Solubility : | 0.226 mg/ml ; 0.00136 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.38 |
Solubility : | 0.695 mg/ml ; 0.00421 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With diphenylsilane; caesium carbonate In acetonitrile at 80℃; for 72 h; Schlenk technique; Inert atmosphere | 1) In a glove box, 0.25 mmol of amantadine,6 equiv (1.5 mmol) of diphenylsilane,10 molpercent (based on amantadine) Cesium carbonate,1.6 ml of acetonitrile solvent was added to 50 ml of a Schlenk tube protected with N2. 2) The N2 in the Schlenk tube was replaced by CO2 in the double-row tube under refrigeration vacuum operation,The pressure of CO2 is 1 bar. 3) using said cesium carbonate as a catalyst,Said carbon dioxide being a C1 source,The diphenylsilane is used as a reducing agent,The amantadine was reacted in an acetonitrile solvent at 80 ° C for 72 hours. 4) After completion of the reaction,To the Schlenk tube was added 0.2 mmol of ferrocene as the internal magnetic standard. 5) By Bruker NMR analysis,The NMR spectra of the resulting product are consistent with the literature (P. Besenius, P. A. G. Cormack, R. F. Ludlow, S. Otto, D. C. Sherrington, Chem. Commun. 2008,In the report of the corresponding pure substance spectrum consistent,In this embodimentN-methylamantanamineYield> 95percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With hydrogen In hexane at 140℃; for 7 h; Autoclave; Inert atmosphere | To a volume of 50 mL of Hastelloy autoclave was placed 10 mL of solvent n-hexane,1 mmol of amantadine,A certain amount of Au / Al2O3 catalyst (containing 5μmol)The autoclave was sealed and the inside of the autoclave was replaced with nitrogen three times,And then into the 1MPa of CO2 gas and 3MPa of H2,Keep the kettle gas pressure at 4MPa,Placed on the chassis with aluminum block on the magnetic stirrer,So that the temperature quickly rose to 140 ,Open the magnetic stirring,Stirring at 1000 rpm for 7 hours,After cooling, add a certain amount of n-octane as the internal standard,Using gas chromatography (FID detector),N-methylamine adamantine yield was 55percentThe yield of N, N-dimethyl-amantadine was 45percentNo other byproducts are generated. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37 %Chromat. | at 150℃; for 5 h; Autoclave | 6.0 mg (0.01 mmol) of complex 1 produced in Reference Example 1 and 303 mg (2 mmol) of 1-adamantylamine were added to a 100 ml stainless autoclave, nitrogen substitution was conducted, and 2 ml of methanol was then added thereto. Next, 1.1 ml (1.2 mmol) of 1.13 M methanol solution of NaOMe was added, and the mixture was then stirred at 150° C. for 5 hours. After cooling, the reactant was analyzed by GC, and N-methyladamantylamine was obtained at a GC yield of 19percent and N,N-dimethyladamantylamine was obtained at a GC yield of 37percent. |
[ 53075-09-5 ]
N,N,N-Trimethyladamantan-1-aminium hydroxide
Similarity: 0.87
[ 102-45-4 ]
1-Cyclopentyl-N-methylpropan-2-amine
Similarity: 0.86
[ 351329-88-9 ]
N-(3,5-Dimethyladamantan-1-yl)formamide
Similarity: 0.80
[ 53075-09-5 ]
N,N,N-Trimethyladamantan-1-aminium hydroxide
Similarity: 0.87
[ 102-45-4 ]
1-Cyclopentyl-N-methylpropan-2-amine
Similarity: 0.86
[ 36768-62-4 ]
4-Amino-2,2,6,6-tetramethylpiperidine
Similarity: 0.83
[ 351329-88-9 ]
N-(3,5-Dimethyladamantan-1-yl)formamide
Similarity: 0.80